Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Federal Trade Commission
US Department of Justice
Cantor Fitzgerald
Argus Health
Express Scripts

Generated: December 14, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Sodium Sulamyd, and when can generic versions of Sodium Sulamyd launch?

Sodium Sulamyd is a drug marketed by Schering and is included in one NDA.

The generic ingredient in SODIUM SULAMYD is sulfacetamide sodium. There are three drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
Drug patent expirations by year for SODIUM SULAMYD

Medical Subject Heading (MeSH) Categories for SODIUM SULAMYD

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
ScheringSODIUM SULAMYDsulfacetamide sodiumOINTMENT;OPHTHALMIC005963-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
ScheringSODIUM SULAMYDsulfacetamide sodiumSOLUTION/DROPS;OPHTHALMIC005963-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
ScheringSODIUM SULAMYDsulfacetamide sodiumSOLUTION/DROPS;OPHTHALMIC005963-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Boehringer Ingelheim
Express Scripts
US Army
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: